MAVERIC Phase III pivotal trial of orphan drug candidate CardiolRx in recurrent pericarditis is fully funded through to a planned New Drug Application submission with the FDA. New data from the ARCHER trial, highlighting the magnitude of reduction in left ventricular (LV) mass and the read through to heart failure,…
This week was marked by strong, event-driven volatility across the tech sector. Market moves were shaped by artificial intelligence…
/NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRE SERVICES/ finlay minerals ltd. (TSXV: FYL,OTC:FYMNF) (OTCQB: FYMNF)…
AF2 Capital Corp. (TSXV: AF.P) (‘AF2‘ or the ‘Company‘) is pleased to announce it has entered into a non-binding…
Tactical Resources Corp (TSXV:RARE)(OTC PINK:USREF) (“Tactical Resources” or the “Company”), a mineral exploration and development company, today announced a…
The Governments of the United States and the Democratic Republic of the Congo (DRC) co-hosted the U.S.–DRC Economic and…
Don Durrett of GoldStockData.com outlines current gold and silver market dynamics, explaining why the metals continue to rise and…
RemSense Technologies (REM:AU) has announced Strategic Entry into Australian Gas Infrastructure Sector Download the PDF here. This post appeared…
Carbonxt Group (CG1:AU) has announced Convertible Note and Placement Download the PDF here. This post appeared first on investingnews.com